ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses

Clin Lung Cancer. 2018 Sep;19(5):457-459. doi: 10.1016/j.cllc.2018.05.015. Epub 2018 Jun 5.
No abstract available

Keywords: ROS1; Thrombosis; Venous thromboembolic event.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / genetics
  • Adenocarcinoma / pathology
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Biomarkers, Tumor / genetics
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Factor V / genetics*
  • Female
  • Gene Rearrangement*
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / genetics
  • Lung Neoplasms / pathology
  • Male
  • Middle Aged
  • Prognosis
  • Protein-Tyrosine Kinases / genetics*
  • Proto-Oncogene Proteins / genetics*
  • Recurrence
  • Venous Thrombosis / chemically induced
  • Venous Thrombosis / genetics
  • Venous Thrombosis / pathology*

Substances

  • Biomarkers, Tumor
  • Proto-Oncogene Proteins
  • factor V Leiden
  • Factor V
  • Protein-Tyrosine Kinases
  • ROS1 protein, human